• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Working ability and exercise tolerance during treatment of a mild hypertension. I. Comparison between a beta-adreno-receptor blocking drug and a calcium antagonist.

作者信息

Lange Andersen K, Piatkowski W, Green K A, Ottmann W

出版信息

Int Arch Occup Environ Health. 1985;56(1):41-7. doi: 10.1007/BF00380699.

DOI:10.1007/BF00380699
PMID:2863220
Abstract

A randomized cross-over trial was undertaken on 21 occupationally active persons who had a stable mild or moderate hypertension with the purpose of comparing the effect of a beta-adreno-receptor blocking agent (atenolol) with that of a calcium channel inhibitor (nifedipine). The doses recommended by the manufactures were used. Atenolol (100 mg) given once a day resulted in a marked hypotensive effect at rest as well as during exercise, the compliance was satisfactory, and the hemodynamic changes were not reflected in unfavourable side effects during muscular exercise or in the subjects own personal assessment of fatigue during the exercise tests which ranged in energy expenditure from about three to six times the resting level. However, unfavourable, modest side effects occurred in two subjects during atenolol medication to the extent that they wanted to terminate the study. Nifedipine therapy with doses of 10 mg, three times a day, resulted in a modest, but statistically insignificant reduction in arterial blood pressure, which contrasts with previous published results. It is suggested that the modest effect is caused or related to the poor compliance and a daily dose that was quantitatively too small. No unfavourable side effects were seen during muscular efforts when the subjects were on nifedipine medication.

摘要

相似文献

1
Working ability and exercise tolerance during treatment of a mild hypertension. I. Comparison between a beta-adreno-receptor blocking drug and a calcium antagonist.
Int Arch Occup Environ Health. 1985;56(1):41-7. doi: 10.1007/BF00380699.
2
Working ability and exercise tolerance during treatment of mild hypertension. II. A comparison between atenolol and prazosin medication.轻度高血压治疗期间的工作能力与运动耐量。II. 阿替洛尔与哌唑嗪药物治疗的比较。
Int Arch Occup Environ Health. 1985;56(1):49-55. doi: 10.1007/BF00380700.
3
[Atenolol/nifedipine combination: efficacy and tolerability of low dose synergistic bitherapy in the treatment of arterial hypertension].阿替洛尔/硝苯地平联合用药:低剂量协同双药疗法治疗动脉高血压的疗效及耐受性
Drugs. 1998;56 Suppl 2:31-43. doi: 10.2165/00003495-199856002-00004.
4
Multicenter placebo-controlled comparison of amlodipine and atenolol in mild to moderate hypertension.氨氯地平和阿替洛尔治疗轻至中度高血压的多中心安慰剂对照比较
J Cardiovasc Pharmacol. 1988;12 Suppl 7:S107-9. doi: 10.1097/00005344-198812007-00024.
5
Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone.阿替洛尔联合硝苯地平用于单药固定剂量治疗无效的轻至中度系统性高血压。
Am J Cardiol. 1986 Apr 15;57(11):965-70. doi: 10.1016/0002-9149(86)90740-x.
6
Nitrendipine and atenolol: comparison and combination in the treatment of arterial hypertension.尼群地平和阿替洛尔:治疗动脉高血压的比较与联合应用
Arzneimittelforschung. 1985;35(4):727-9.
7
A randomized placebo-controlled comparison of amlodipine and atenolol in mild to moderate systemic hypertension.氨氯地平和阿替洛尔治疗轻至中度系统性高血压的随机安慰剂对照比较。
J Cardiovasc Pharmacol. 1988;12 Suppl 7:S103-6. doi: 10.1097/00005344-198812007-00023.
8
Efficacy and tolerability of atenolol, nifedipine and their combination in the management of hypertension.阿替洛尔、硝苯地平及其联合用药治疗高血压的疗效与耐受性
Drugs. 1988;35 Suppl 4:29-35. doi: 10.2165/00003495-198800354-00008.
9
The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group.欧洲总缺血负荷试验(TIBET)。阿替洛尔、缓释硝苯地平及其联合用药对608例稳定型心绞痛患者运动试验及总缺血负荷的影响。TIBET研究组
Eur Heart J. 1996 Jan;17(1):96-103. doi: 10.1093/oxfordjournals.eurheartj.a014699.
10
The efficacy and tolerability of atenolol, nifedipine, and their combination in the management of hypertension.阿替洛尔、硝苯地平及其联合用药治疗高血压的疗效与耐受性。
Eur J Clin Pharmacol. 1988;34(6):543-8. doi: 10.1007/BF00615215.

引用本文的文献

1
Patient compliance and therapeutic coverage: comparison of amlodipine and slow release nifedipine in the treatment of hypertension. The Belgian Collaborative Study Group.患者依从性与治疗覆盖率:氨氯地平和缓释硝苯地平治疗高血压的比较。比利时协作研究组。
Eur J Clin Pharmacol. 1995;47(6):477-81. doi: 10.1007/BF00193697.
2
Working ability and exercise tolerance during treatment of mild hypertension. II. A comparison between atenolol and prazosin medication.轻度高血压治疗期间的工作能力与运动耐量。II. 阿替洛尔与哌唑嗪药物治疗的比较。
Int Arch Occup Environ Health. 1985;56(1):49-55. doi: 10.1007/BF00380700.
3
[Have angiotensin-converting enzyme inhibitors improved therapy of hypertension?].

本文引用的文献

1
Calcium blockade as a therapeutic principle in arterial hypertension. Clinical aspects and experimental studies on isolated vessels from spontaneously hypertensive rats and normotensive man.钙通道阻滞作为动脉高血压治疗原则。对自发性高血压大鼠和正常血压人类的离体血管进行的临床研究和实验研究
Acta Pharmacol Toxicol (Copenh). 1981;49 Suppl 2:1-31. doi: 10.1111/j.1600-0773.1981.tb03365.x.
2
Nifedipine or verapamil as sole treatment of hypertension. An intraarterial study.硝苯地平或维拉帕米作为高血压的单一治疗方法。一项动脉内研究。
Hypertension. 1983 Jul-Aug;5(4 Pt 2):II91-6. doi: 10.1161/01.hyp.5.4_pt_2.ii91.
3
Pharmacokinetic studies of nifedipine tablet. Correlation with antihypertensive effects.
血管紧张素转换酶抑制剂是否改善了高血压的治疗?
Klin Wochenschr. 1988 Sep 15;66(18):920-3. doi: 10.1007/BF01728955.
硝苯地平片的药代动力学研究。与降压效果的相关性。
Hypertension. 1983 Jul-Aug;5(4 Pt 2):II29-33. doi: 10.1161/01.hyp.5.4_pt_2.ii29.
4
Hemodynamic changes after acute and long-term combined alpha--beta-adrenoceptor blockade with labetalol as compared with beta-receptor blockade.
J Cardiovasc Pharmacol. 1981;3 Suppl 1:S30-41. doi: 10.1097/00005344-198100031-00004.
5
beta-adrenoceptor blockade and physical activity: cardiovascular and metabolic aspects.β-肾上腺素能受体阻断与体力活动:心血管和代谢方面
Acta Med Scand Suppl. 1983;672:55-62. doi: 10.1111/j.0954-6820.1983.tb01614.x.
6
Adrenergic control of lipid metabolism.脂质代谢的肾上腺素能控制
Acta Med Scand Suppl. 1983;672:41-4. doi: 10.1111/j.0954-6820.1983.tb01612.x.
7
Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension.阿替洛尔、美托洛尔、美托洛尔缓释片和氧烯洛尔缓释片治疗原发性高血压的比较研究
Br Heart J. 1981 Nov;46(5):498-502. doi: 10.1136/hrt.46.5.498.
8
Effect of propranolol and prazosin on blood lipids. The Oslo Study.普萘洛尔和哌唑嗪对血脂的影响。奥斯陆研究。
Lancet. 1980 Jul 5;2(8184):4-6. doi: 10.1016/s0140-6736(80)92888-3.
9
Perceived exertion as an indicator of somatic stress.自觉用力程度作为躯体应激的一个指标。
Scand J Rehabil Med. 1970;2(2):92-8.
10
Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade.心血管钙拮抗剂在有无β-肾上腺素能阻滞剂情况下对高血压患者的降压作用。
Am Heart J. 1978 Aug;96(2):218-26. doi: 10.1016/0002-8703(78)90089-3.